* Apollo Medical Holdings Inc AMEH.OQ AMEH.O is expected
to show a rise in quarterly revenue when it reports results on
February 23.
* The Alhambra California-based company is expected to
report a
26.0% increase in revenue to $245.847 million from $195.1
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Apollo Medical
Holdings
Inc is for a loss of 9 cents per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Apollo
Medical
Holdings Inc is $39, above its last closing price of $33.22.
This summary was machine generated February 22 at 03:02 GMT.
All figures in US dollars unless otherwise stated